What You Should Know:
- The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in line with the S&P 500 decline of 16.4%.
- Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. The report reveals credit markets likely to tighten, but a healthy level of M&A is expected to continue in the growing and defensive healthcare sector.
Key Trends and
Read More
Healthcare Private Equity | PE | M&A| News, Analysis, Insights
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
M&A: Bain Capital Acquires Majority Stake in LeanTaaS
What You Should Know:
- Private equity firm Bain Capital has acquired a majority stake in the company in LeanTaaS, a leading provider of cloud software solutions for optimizing hospital operations and capacity management that will enable LeanTaaS to accelerate its rapid growth trajectory.
- LeanTaaS’ cloud-based iQueue solutions help hospitals transform their approach to care delivery and improve capital and scarce resource decision-making by optimizing the utilization of
Read More
PE Firm Acquires Intelligent Medical Objects (IMO) for $1.5B+
What You Should Know:
- Thomas H. Lee Partners, a premier private equity firm investing in growth companies, announced today that it has entered into an agreement to acquire a majority interest in Intelligent Medical Objects, a healthcare data enablement company and market leader in clinical terminology solutions in a $1.5B + deal.
- Founded in 1994, IMO manages more than 5 million clinical terms and maps to all major coding systems. Its suite of software products, which is used by over
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
How Support Automation Enhances Clinical Trial Management
The life of a clinical study relies on data from documentation, meetings, emails and calls; all of which can be overwhelming for patients, clinical trial teams and associates. Although mundane, documenting, executing and collecting data is crucial to move a trial from phase to phase.
Clinical trial teams face a multitude of competing priorities, from evaluating hundreds of potential patients to maintaining compliance and recording patient progress. No aspect or step can be neglected for a
Read More
GTCR Acquires Majority Stake in Experity to Drive On-Demand Care
What You Should Know:
- Experity, the national leader in on-demand care solutions, today announced a strategic growth investment from GTCR, a private equity firm with significant experience in healthcare technology and services. Existing investor Warburg Pincus will retain a minority interest in the company
- The strategic growth investment from GTCR, along with the combined capability of two world-class investors (including Warburg Pincus) will provide industry-leading innovation and
Read More
PE Firm WCAS Launches $300M Value-Based Care Portfolio Company, Valtruis
What You Should Know:
Welsh, Carson, Anderson & Stowe (“WCAS”), a leading private equity firm focused exclusively on the healthcare and technology industries, announced that it is launching Valtruis, a unique portfolio company that will invest in and partner with value-based care driven healthcare companies. WCAS is committing an initial $300M to this platform.
Founded on a commitment to accelerate meaningful change, Valtruis brings the functional expertise, access to capital and an
Read More
PE Firm Warburg Pincus Makes Minority Investment in GHX, Thoma Bravo Exits
What You Should Know:
- GHX, a healthcare supply chain leader announced it has entered into a definitive agreement to receive a strategic investment from private equity firm Warburg Pincus. As part of this transaction, minority investor Thoma Bravo has exited its investment. Existing investor Temasek, an investment company headquartered in Singapore, will remain the majority equity holder.
- GHX has employees in the United States, Canada and Europe and is known for operating the largest
Read More
PE Firm Frazier Healthcare Partners Closes $1.4B Growth Buyout Fund
What You Should Know:
- Frazier Healthcare Partners, a Seattle-based healthcare private equity firm announced the close of its tenth global buyouts fund and 13th fund across buyouts and life sciences. Investment focus will continue to be middle market provider-based businesses, with virtual health as a major component. The oversubscribed $1.4 billion fund, FHGB X, is significantly larger than FHGB IX, which closed at $780M in 2018.
- Frazier, 30 years strong this year,
Read More
